Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Withdrawn NGC Summaries

Use the index below to find guidelines (listed by guideline developer) that have been withdrawn from the NGC Web site. Select "All" to see a complete list of withdrawn NGC Guideline Summaries (organized alphabetically by guideline developer). For a list of guidelines that have been updated, go to Updated NGC Summaries.

Guideline summaries are removed from the NGC Web site because they no longer meet the NGC Inclusion Criteria with respect to date, or because the guideline developer has indicated that the clinical practice guideline upon which the summary is based is obsolete, should no longer be used, or has not yet been replaced with a new/revised guideline. Please refer to the guideline developer's Web site, where available, for more information.

Note to PC users: If you are not sure which developer you need, consider using the "Find" option under the Edit menu or select Control-F to search the complete list by keyword.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

The National Guideline Clearinghouse™ currently contains 1140 guidelines in the withdrawn archive.

Finnish Medical Society Duodecim

  1. Atrial fibrillation: drug treatment and electric cardioversion. (NGC-4094)
    • Finnish Medical Society Duodecim. Atrial fibrillation: drug treatment and electric cardioversion. In: EBM Guidelines. Evidence-Based Medicine [CD-ROM]. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2004 Sep 14 [Various].

For more information, please refer to the Finnish Medical Society Duodecim Web site.

Florida Agency for Health Care Administration

  1. Management of pain using dangerous drugs and controlled substances. (NGC-1028)
    • Agency for Health Care Administration (AHCA). Management of pain using dangerous drugs and controlled substances. Tallahassee (FL): State of Florida, Agency for Health Care Administration; 1996 Oct 25. 16 p. (Medical practice guidelines).

  2. Universe of Florida patients with acute ischemic brain attack. (NGC-1027)
    • Agency for Health Care Administration (AHCA). Universe of Florida patients with acute ischemic brain attack. Tallahassee (FL): State of Florida, Agency for Health Care Administration; 1999 Mar 5. 16 p. [134 references]

  3. Universe of Florida patients with low back pain or injury. (NGC-1026)
    • Agency for Health Care Administration (AHCA). Universe of Florida patients with low back pain or injury. Tallahassee (FL): State of Florida, Agency for Health Care Administration; 1996 Feb 2. 32 p. (Medical practice guideline). [464 references]

  4. Universe of Florida patients with neck pain or injury. (NGC-1025)
    • Agency for Health Care Administration (AHCA). Universe of Florida patients with neck pain or injury. Tallahassee (FL): State of Florida, Agency for Health Care Administration; 1996 Mar 15. 23 p. (Medical practice guidelines). [401 references]

For more information, please refer to the Florida Agency for Health Care Administration Web site.

Food and Drug Administration (U.S.)

  1. Potassium iodide as a thyroid blocking agent in radiation emergencies. (NGC-2315)
    • Potassium Iodide Working Group. Guidance document. Potassium iodide as a thyroid blocking agent in radiation emergencies. Rockville (MD): U.S. Food and Drug Administration, Center for Drug Evaluation and Research; 2001 Nov. 12 p. [31 references]

For more information, please refer to the Food and Drug Administration (U.S.) Web site.